DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Research Report on China In-vitro Diagnostic Reagent Industry, 2017-2021" report to their offering.
The market size of China in-vitro diagnostic reagents reached about CNY 26 billion (USD 3.9 billion) in 2016, of which the leading three were immune, biochemical and molecular products.
In terms of industry regulatory policies, laws and regulations together with industry policies concerning China in-vitro diagnostic industry are gradually consistent with international conventions. CFDA started to implement strict supervision on the IVD industry from 2014. A series of policies were issued to supervise various links including R&D, production, registration, clinics, circulation and sales, and large-scale shuffle was carried out on the IVD industry through strict industry access and operation requirements.
In China, major consumption demand for in-vitro diagnostic reagents derives from medical testing and blood screening. Medical testing is the major consumer of in-vitro diagnostic reagents including hospital clinical laboratory, physical examination center, independent laboratory and epidemic prevention station.
Meanwhile, blood screening is mainly applied in blood collection and supply departments including various blood stations and blood product manufacturers. Presently, hospitals are major demand markets of in-vitro diagnostic reagents in China.
Key Topics Covered:
1 Basic Concepts of In-vitro Diagnostic Reagent Industry
2 Analysis on Global In-vitro Diagnostic Industry, 2011-2016
3 Development Environment of China In-vitro Diagnostic Reagent Industry, 2011-2016
4 Operation Status of China Diagnostic Reagent Industry, 2011-2016
5 Analysis on Competition in China In-vitro Diagnostic Reagent Industry, 2011-2016
6 Analysis on Major Manufacturers of In-vitro Diagnostic Reagents in China, 2013-2016
7 Prospect of China In-vitro Diagnostic Reagent Industry, 2017-2021
- Abbott Laboratories
- Beckman Coulter
- Beijing Leadman Biochemistry Co., Ltd.
- BioSino Bio-technology and Science Inc.
- DAAN Gene Co., Ltd. of Sun Yat-sen University
- F. Hoffmann-La Roche Ltd
- Shanghai Fosun Pharmaceutical Co., Ltd.
- Shanghai Kehua Bio-engineering Co., Ltd.
- Shenzhen Mindray Bio-medical Electronics Co., Ltd.
- Sichuan Maccura Biotechnology Co., Ltd.
- Siemens AG
For more information about this report visit http://www.researchandmarkets.com/research/6fsmg3/research_report